Navigation Links
Diopsys Receives CE Mark for its VEP Vision Testing Systems
Date:11/2/2011

PINE BROOK, N.J., Nov. 2, 2011 /PRNewswire/ -- Diopsys, Inc. announced today that its Visual Evoked Potential (VEP) Vision Testing Systems have been awarded the CE mark. The company has begun a roll-out of its patented vision testing devices to EU customers.

Diopsys completed a rigorous inspection of its total quality system in order to qualify for CE status.  "Having the CE mark opens many opportunities for us to provide clinicians and patients across the EU access to our advanced VEP technology," says Joseph Fontanetta, CEO of Diopsys, "Our VEP devices are designed to be used in an office setting and our patented technology overcomes many limitations of traditional VEP devices. Testing times are much faster than older VEP devices and our reports are easier to interpret. We are proud to bring an operator-friendly, objective, functional vision test to patients in need."

Diopsys is the developer and marketer of the Diopsys® NOVA-VEP Vision Testing Systems utilized by ophthalmologists and optometrists to aid in the detection, diagnosis and treatment of vision disorders, including glaucoma, a disease affecting millions globally. The company has also developed and markets the Enfant® Pediatric VEP Vision Testing System, a device used to test for visual deficits, including amblyopia, in children as young as six months of age.

Visual Evoked Potentials (VEPs) are electrical signals that are a measure of the electrophysiological activity at the visual cortex. VEP results are a representation of the functional integrity of all levels of the visual pathway including the eye, retina, optic nerve, and visual cortex. This technology has been used for a variety of applications that involve neuro-visual disorders such as glaucoma, amblyopia, multiple sclerosis and diabetic retinopathy, among many others.(1,2,3,4 )

About Diopsys

Diopsys, Inc. (www.diopsys.com) is a medi
'/>"/>

SOURCE Diopsys, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Diopsys, Inc. Launches New Website for Doctors and Patients, www.Diopsys.com
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly larger ... painless for patients to self-inject prescription drugs in the large ... cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to $220B by 2018, according to analysts.   Many of these ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
... today announced that Jeff Abbey , the ... of its Arcelis™ dendritic cell-based immunotherapy at 3:30 ... Conference in New York. In addition, Charles ... president of research and development, will participate in a panel ...
... 18 URAC, a leading independent health care quality ... (MRM) program the Bronze Award in Health Information/Decision Support ... Empowerment and Protection Awards. The awards honor programs that ... The Oklahoma Health Care Authority (OHCA) and Oklahoma Department ...
Cached Medicine Technology:Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference 2Health Care Coordination Program Honored With URAC National Best Practices Award 2Health Care Coordination Program Honored With URAC National Best Practices Award 3Health Care Coordination Program Honored With URAC National Best Practices Award 4
(Date:4/20/2014)... A single type of cell in the lining ... invasive bladder cancer, according to researchers at the Stanford ... mice, is the first to pinpoint the normal cell ... It,s also the first to show that most bladder ... one cell, and explains why many human bladder cancers ...
(Date:4/18/2014)... published online in The Gerontologist ... is associated with a decrease in anxiety about death ... control over their lives. In particular, listening to gospel ... death and an increase in sense of control. , ... and men, and individuals of both low- and high-socioeconomic ...
(Date:4/18/2014)... worst memories? How did it make you feel? According ... personal experience, such as how sad you were or ... especially when you can,t stop thinking about it. ... the context of the memories, rather than how you ... alleviate the negative effects of these memories, a new ...
(Date:4/18/2014)... (April 18, 2014) ― A new study in the ... patterns in health-related Google searches reveals a recurring pattern ... , Investigators from San Diego State University, ... Monday Campaigns, analyzed "healthy" Google searches (searches that included ... diet") originating in the U.S. from 2005 to 2012. ...
(Date:4/17/2014)... in benign prostate tissue was associated with high-grade, ... found even in those with low prostate-specific antigen ... Cancer Epidemiology, Biomarkers & Prevention , a ... , An analysis of prostate tissue biopsies collected ... the Prostate Cancer Prevention Trial (PCPT) found that ...
Breaking Medicine News(10 mins):Health News:Stanford scientists identify source of most cases of invasive bladder cancer 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 3Health News:Stanford scientists identify source of most cases of invasive bladder cancer 4Health News:Stanford scientists identify source of most cases of invasive bladder cancer 5Health News:Religious music brings benefit to seniors' mental health 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3
... Association of California Nurse Leaders Supports Research Efforts ... AMN Healthcare congratulates Tanya Osborne-McKenzie, RN, who was ... the 31st annual Association of California Nurse Leaders ... by ACNL. Osborne-McKenzie is the director of ...
... 26 Digital Power Corporation (NYSE Amex: DPW ... and for the year ended December 31, 2008.Digital Power reported ... 3l, 2008, compared to net income of $235,000 for the ... for the fourth quarter of 2008, compared to operating income ...
... SCIENTIST: A GUIDE TO RESPONSIBLE CONDUCT IN RESEARCH, THIRD ... Academy of Engineering, and Institute of Medicine, offers researchers ... on the ethical conduct of scientific research. ... to help readers consider how to respond in complex ...
... Specialized Leases from Elekta Facilitate Sharing of Financial ... health systems are facing a "perfect storm" as ... layoffs and federal cuts, and investment income dwindles. ... from other medical facilities, but from new entrants ...
... Coast Independent Review Board (IRB), testified today before the Subcommittee ... Committee in the Rayburn House Office Building. Coast IRB ... clandestine sting operation at the request of the Committee. ... Coast had committed any crime. No crime was unearthed ...
... to aid in recognizing, treating rare but real condition ... about the symptoms and outcomes of a relatively rare ... been collected by U.S. researchers into a registry of ... 70 people in the new registry -- nearly all ...
Cached Medicine News:Health News:Tanya Osborne-McKenzie Wins AMN Healthcare ACNL Scholarship 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 4Health News:New Focus Placed on Alternative Financing as Hospitals Seek Competitive Advantage During Challenging Economic Conditions 2Health News:New Focus Placed on Alternative Financing as Hospitals Seek Competitive Advantage During Challenging Economic Conditions 3Health News:Coast IRB Tells Congressional Committee Sting Operation Was Illegal, Unnecessarily Harmful 2Health News:Registry Created for Broken Heart Syndrome 2
... a electronic medical records software for healthcare ... Medical Office Records does more than just ... to follow the flow of your patient ... encounters to establishing new examination records via ...
... The eCHARMS suite comprises the ... 2000 product line. Currently, there ... signature & enterprise-wide disclosure reporting. ... new HIM management tool. These ...
... Electronic Medical Office (EMO) truly built for ... unique needs of your practice. The ChartLogic™ ... record system (EMR, EHR, and EPR), and ... new level of efficiency and performance. In ...
... serving the needs of orthopaedic practices ... a better orthopaedic practice, an orthopaedic ... EMR software has been intuitively developed ... country resulting in a complete workflow ...
Medicine Products: